Microglial CD44 expression is elevated following stroke (Sawada et al., 2020), ALS (Sawada et al., 2020), glioma (Du et al., 2022), and Alzheimer’s disease (Rangaraju et al., 2018). Here, CD44 is linked to early-onset autosomal dominant Alzheimer disease.